Inherited thrombophilia and stratification of ischaemic stroke risk among users of oral contraceptives

Pezzini, A.; Grassi, M.; Iacoviello, L.; del Zotto, E.; Archetti, S.; Giossi, A.; Padovani, A.
March 2007
Journal of Neurology, Neurosurgery & Psychiatry;Mar2007, Vol. 78 Issue 3, p271
Academic Journal
Background: Whether use of oral contraceptives is a risk factor for arterial ischaemic stroke is controversial. In particular, few data are available on what criteria should be adopted to establish an individual profile of risk before the start of oral contraceptives. Patients and methods: The effects of oral contraceptives and their interaction with the G1691A polymorphisms of the factor V gene, the G20210A polymorphisms of the prothrombin gene and the C677T polymorphisms of the MTHFR gene on the risk of cerebral ischaemia were determined in a series of 108 consecutive women aged <45 years with ischaemic stroke and 216 controls, in a hospital-based case-control study design. Results: Use of oral contraceptives was associated with an increased risk of cerebral ischaemia (odds ratio (OR) 3.95; 95% confidence interval (CI) 2.29 to 6.78). ORs for stroke were 2.25 (95% Cl 1 .15 to 4.40), 3.94 (95% CI 2.28 to 6.81) and 8.87 (95% CI 3.72 to 21.1) for non-oral contraceptive users with the TT MTHFR genotype, oral contraceptive users without the TT MTHFR genotype and oral contraceptive users with the TT MTHFR genotype, respectively, when compared with non-oral contraceptive users without the TT MTHFR genotype, with a multiplicative independent effect. Compared with non-oral contraceptive users, ORs for stroke were 2.65 (95% CI 1.46 to 4.81) for oral contraceptive users with none of the studied polymorphisms and 22.8 (95% CI 4.46 to 116.00) for oral contraceptive users with at least one of the studied polymorphisms, with a synergistic effect. Conclusions: Exposure to the effects of oral contraceptives may increase the risk of ischaemic stroke in women with an inherited prothrombotic background. Testing for these genetic variants may allow more accurate stratification of the population at risk before long-term use of oral contraceptives is prescribed.


Related Articles

  • New treatments, new risk factors for acute ischemic stroke.  // Patient Care;3/30/1999, Vol. 33 Issue 6, p144 

    Focuses on stroke or cerebral vascular disease. Risk factors for acute ischemic attacks; Treatment modalities; Clinical management; Drugs of choice. INSET: Atrial fibrillation: A treatable risk factor..

  • Primary prevention for ischemic stroke.  // Patient Care;3/30/1999, Vol. 33 Issue 6, p164 

    Discusses primary preventive measures for transient ischemic stroke, a type of cerebrovascular disease. Risk factors; Includes smoking; Hypertension; Poor diet exercise habits; Drug therapy.

  • Factor V Leiden mutation and patent foramen ovale in ischemic stroke. Bezzi, G.; Bolzani, W.; Compagnoni, V.; Galimi, R.; Palmieri, M.G.; Bianchi, C. // Neurological Sciences;Dec2002, Vol. 23 Issue 5, p229 

    We report a 47-years-old male with ischemic stroke, whose arteriographic and echocardiographic investigations did not reveal any steno-occlusive arterial disease or embolic source from the left cardiac chambers. A transesophageal echocardiogram showed a patent foramen ovale (PFO), whilst...

  • Correction: Cerebral ischemia induces microvascular pro-inflammatory cytokine expression via the MEK/ERK pathway. Maddahi, Aida; Edvinsson, Lars // Journal of Neuroinflammation;2011, Vol. 8 Issue 1, p18 

    A correction to the article "Cerebral ischemia induces microvascular pro-inflammatory cytokine expression via the MEK/ERK pathway," published in a previous issue is presented.

  • RISK FACTORS AND PROGNOSIS OF ISCHEMIC STROKE IN YOUNG PATIENTS IN UZBEKISTAN. Sagatov, Dilshod; Rasulova, Khurshidakhon; Madjidova, Yakutkhon // Medical & Health Science Journal;Apr2011, Vol. 5 Issue 1, p16 

    Between 2004 and 2008, we studied reasons and risk factors of ischemic stroke in 150 young patients (aged between 17-44 years), compared with those in elderly patients (n=70). According to our data, heredity, arterial hypertension, cerebral vasculitis, thyroid diseases, chronic alcoholism,...

  • Genetic Polymorphisms of Type-1 and Type-2 Inflammatory Cytokines in Ischaemic Stroke. Marousi, Stella; Ellul, John; Karakantza, Marina // Vascular Disease Prevention;May2008, Vol. 5 Issue 2, p89 

    Inflammation is a key process linked to stroke both in terms of atherosclerosis, and in terms of cerebral ischaemia. Secondary to endothelial injury, innate and acquired immune mechanisms maintain a chronic low-grade inflammatory state, which initially contributes to formation of atherosclerotic...

  • STROKE IN USERS OF LOW-DOSE ORAL CONTRACEPTIVES. Zamorski, Mark // Journal of Family Practice;Oct1996, Vol. 43 Issue 4, p343 

    This article focuses on a study that was conducted to analyze the role of oral contraceptives containing less than 50 microgram estrogen, as a risk factor for stroke. A number of epidemiological studies from the 1960's and 1970's suggested that women taking oral contraceptives (OCs) had an...

  • The rapid decrease in astrocyte-associated dystroglycan expression by focal cerebral ischemia is protease-dependent. Milner, Richard; Hung, Stephanie; Xiaoyun Wang; Spatz, Maria; Del Zoppo, Gregory J. // Journal of Cerebral Blood Flow & Metabolism;Apr2008, Vol. 28 Issue 4, p812 

    During focal cerebral ischemia, the detachment of astrocytes from the microvascular basal lamina is not completely explained by known integrin receptor expression changes. Here, the impact of experimental ischemia (oxygen–glucose deprivation (OGD)) on dystroglycan expression by murine...

  • Protein phosphatase-2A is activated in pig brain following cardiac arrest and resuscitation. Tao Zhang // Metabolic Brain Disease;Mar2008, Vol. 23 Issue 1, p95 

    Abstract  Protein phosphatase-2A (PP-2A) interacts with several regulators of cell death pathways and is therefore a potential component of signaling pathways linking global cerebral ischemia to cell death. Using a novel procedure to quantify PP-2A activity, we find that cardiac...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics